Cargando…

Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients

BACKGROUND: Immune responses on SARS-CoV-2 vaccination in patients receiving anti-CD20 therapies are impaired but vary considerably. We conducted a systematic review and meta-analysis of the literature on SARS-CoV-2 vaccine induced humoral and cell-mediated immune response in patients previously tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schietzel, Simeon, Anderegg, Manuel, Limacher, Andreas, Born, Alexander, Horn, Michael P, Maurer, Britta, Hirzel, Cedric, Sidler, Daniel, Moor, Matthias B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814433/ https://www.ncbi.nlm.nih.gov/pubmed/35115385 http://dx.doi.org/10.1136/rmdopen-2021-002036

Ejemplares similares

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy
por: Sidler, Daniel, et al.
Publicado: (2022)

Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies – Authors' reply
por: Moor, Matthias B, et al.
Publicado: (2022)

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
por: Moor, Matthias B, et al.
Publicado: (2021)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
por: Andreica, Ioana, et al.
Publicado: (2022)

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma
por: Pouleau, Blandine, et al.
Publicado: (2023)

HPV Vaccination in Immunosuppressed Patients with Established Skin Warts and Non-Melanoma Skin Cancer: A Single-Institutional Cohort Study
por: Bossart, Simon, et al.
Publicado: (2023)

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
por: Liebers, Nora, et al.
Publicado: (2022)

Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
por: Geisen, Ulf M, et al.
Publicado: (2021)

P1342: THE IMPACT OF CLONAL HEMATOPOIESIS ON THE RISK OF SEVERE COVID-19 INFECTION
por: Saiki, Ryunosuke, et al.
Publicado: (2023)

Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
por: Nishikubo, Masashi, et al.
Publicado: (2023)

1342. Clinical failure rates of amoxicillin for the treatment of acute otitis media in young children
por: Frost, Holly M, et al.
Publicado: (2020)

Urinary tetrahydroaldosterone is associated with circulating FGF23 in kidney stone formers
por: Moor, Matthias B., et al.
Publicado: (2022)

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
por: Bitoun, Samuel, et al.
Publicado: (2022)

Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis
por: Stahl, David, et al.
Publicado: (2022)

The truncated IFITM3 facilitates the humoral immune response in inactivated influenza vaccine-vaccinated mice via interaction with CD81
por: Xie, Qian, et al.
Publicado: (2023)

Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
por: Calabrese, Cassandra, et al.
Publicado: (2022)

Sexual assault and abuse committed against family members: An analysis of 1342 legal outcomes and their motivations
por: Blandino, Alberto, et al.
Publicado: (2021)

Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities
por: Chiu, Chun-Hsiang, et al.
Publicado: (2022)

A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice
por: Kim, Eun, et al.
Publicado: (2021)

Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies
por: Nicolas, Philippe, et al.
Publicado: (2022)

Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
por: Meredith, Rhys T., et al.
Publicado: (2023)

Humoral response in Leishmaniasis
por: Conde, Luciana, et al.
Publicado: (2022)

The new impact factor of International Brazilian Journal of Urology is 1.342. Where can we get?
por: Favorito, Luciano A.
Publicado: (2020)

Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation
por: Lindemann, Monika, et al.
Publicado: (2021)

T-cell STAT3 is required for the maintenance of humoral immunity to LCMV
por: McIlwain, David R, et al.
Publicado: (2015)

Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial
por: Schietzel, Simeon, et al.
Publicado: (2022)

Annellated 1,3,4,2-Triazaphospholenes-Simple Modular Synthesis and a First Exploration of Ligand Properties
por: Richter, Ferdinand, et al.
Publicado: (2022)

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
por: Apostolidis, Sokratis A., et al.
Publicado: (2021)

Screening of cognitive performance in kidney transplant recipients: a mini review
por: Schietzel, Simeon, et al.
Publicado: (2023)

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
por: Friedli, Christoph, et al.
Publicado: (2021)

Filarial Lymphedema Patients Are Characterized by Exhausted CD4(+) T Cells
por: Horn, Sacha, et al.
Publicado: (2022)

Prenatal detection and molecular cytogenetic characterization of 19q13.42 microduplication: three reported cases and literature review
por: Zhang, Xinyue, et al.
Publicado: (2021)

Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
por: Money, Kelli M., et al.
Publicado: (2022)

The cellular and humoral immunity assay in patients with complicated urolithiasis
por: Ceban, E, et al.
Publicado: (2017)

Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
por: Saris, Anno, et al.
Publicado: (2021)

Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20
por: Toyofuku, Etsushi, et al.
Publicado: (2022)

Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients
por: Marcos‐Jiménez, Ana, et al.
Publicado: (2021)

Optimization of the Expression Conditions of CGA-N46 in Bacillus subtilis DB1342(p-3N46) by Response Surface Methodology
por: Li, Rui-Fang, et al.
Publicado: (2015)

A 13.42-kb tandem duplication at the ASIP locus is strongly associated with the depigmentation phenotype of non-classic Swiss markings in goats
por: Guo, Jiazhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b18bllboaa024q88nm9f93hb5t